EUVIMEDEUVIMED entdecken
Leserbrief

French dupilumab EAP in toddlers: Durable response or follow‐up bias?

Xiaowei Zhang iD

Journal of the European Academy of Dermatology and Venereology · 2026-07 · 40 (7)

DOI: 10.1111/jdv.70401 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.03.2026. Verfasst von Xiaowei Zhang. Beteiligte Einrichtung: Department of Oncology, Xi'an Central Hospital, Xi'an, Shaanxi, China. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

atopic dermatitisattrition biasdupilumabearly access programreal‐world evidencetoddlers

Autor:innen und Institutionen

  • Department of Oncology, Xi'an Central Hospital, Xi'an, Shaanxi, China.

ORCID-Profile: Xiaowei Zhang

Zitieren

APA

Zhang, X. (2026). French dupilumab EAP in toddlers: Durable response or follow‐up bias?. Journal of the European Academy of Dermatology and Venereology, 40(7). https://doi.org/10.1111/jdv.70401

Vancouver

Zhang X. French dupilumab EAP in toddlers: Durable response or follow‐up bias?. Journal of the European Academy of Dermatology and Venereology. 2026;40(7). doi:10.1111/jdv.70401

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaowei},
  title = {French dupilumab EAP in toddlers: Durable response or follow‐up bias?},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1111/jdv.70401}
}
Kostenlos starten →